ABAG has a total of 13 patent applications. Its first patent ever was published in 2004. It filed its patents most often in France, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are THE CORP OF THE TRUSTEES OF THE ORDER OF THE SISTERS OF MERCY IN QUEENSLAND, MASSACHUSETTS HEALTH RES and ARBOR VITA CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | France | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | EPO (European Patent Office) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Cyncynatus Camille | 10 |
#2 | Nuyttens Helene | 4 |
#3 | Arie Jean Philippe | 4 |
#4 | Arie Jean-Philippe | 4 |
#5 | Roge Julie | 1 |
#6 | Thomas Damien | 1 |
Publication | Filing date | Title |
---|---|---|
FR2930646A1 | In vitro detection of antibodies produced following legionella pneumophila infection | |
WO2008040883A1 | Use of the 7f4 protein in the in vitro diagnosis of mycoplasma pneumoniae infections | |
EP1804061A1 | Use of the 5E2 protein for in vitro diagnosis of infections in Legionella pneumophila | |
FR2886312A1 | New proteins for in vitro diagnosis and prevention of streptococcus pyogenes infections | |
FR2871237A1 | Novel polypeptides for in vitro assessment and prevention of staphylococcal infections on joint prostheses and other foreign abridged materials | |
FR2878861A1 | New proteins for in vitro diagnosis and prevention of legionella pneumophila infections |